NCT05698186 2023-01-26Thero2-01S22 in HER2-positive Breast CancerInstitut de cancérologie Strasbourg EuropePhase 3 Not yet recruiting320 enrolled
NCT05388500 2022-05-27PHARE-CInstitut de cancérologie Strasbourg EuropePhase 3 Not yet recruiting800 enrolled